Matches in DBpedia 2015-04 for { <http://dbpedia.org/resource/Ruxolitinib> ?p ?o }
Showing triples 1 to 79 of
79
with 100 triples per page.
- Ruxolitinib abstract "Ruxolitinib (INC424, INCB18424, trade names Jakafi and Jakavi, by Incyte Pharmaceuticals and Novartis) is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of bone marrow cancer. It is also being investigated for the treatment of other types of cancer (such as lymphomas and pancreatic cancer), for polycythemia vera, for plaque psoriasis, and for alopecia areata.".
- Ruxolitinib atcPrefix "L01".
- Ruxolitinib atcSuffix "XE18".
- Ruxolitinib bioavailability "95.0".
- Ruxolitinib casNumber "941678-49-5".
- Ruxolitinib fdaUniiCode "82S8X8XX8H".
- Ruxolitinib iupacName "(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile".
- Ruxolitinib thumbnail Ruxolitinib2DACS.svg?width=300.
- Ruxolitinib wikiPageID "30809251".
- Ruxolitinib wikiPageRevisionID "629916075".
- Ruxolitinib atcPrefix "L01".
- Ruxolitinib atcSuffix "XE18".
- Ruxolitinib bioavailability "95.0".
- Ruxolitinib c "17".
- Ruxolitinib casNumber "941678".
- Ruxolitinib chembl "1789941".
- Ruxolitinib chemspiderid "25027389".
- Ruxolitinib eliminationHalfLife "-10800.0".
- Ruxolitinib excretion "Urine , faeces".
- Ruxolitinib h "18".
- Ruxolitinib hasPhotoCollection Ruxolitinib.
- Ruxolitinib iupacName "-3".
- Ruxolitinib legalAu "S4".
- Ruxolitinib legalCa "Rx-only".
- Ruxolitinib legalUk "POM".
- Ruxolitinib legalUs "Rx-only".
- Ruxolitinib licenceEu "Jakavi".
- Ruxolitinib licenceUs "Ruxolitinib".
- Ruxolitinib medlineplus "a612006".
- Ruxolitinib metabolism "Hepatic".
- Ruxolitinib molecularWeight "306.37".
- Ruxolitinib n "6".
- Ruxolitinib pregnancyAu "C".
- Ruxolitinib pregnancyUs "C".
- Ruxolitinib proteinBound "97.0".
- Ruxolitinib routesOfAdministration "Oral, topical".
- Ruxolitinib smiles "C1CCCCN2C=CC3=C4C=CNC4=NC=N3".
- Ruxolitinib stdinchi "1".
- Ruxolitinib stdinchikey "HFNKQEVNSGCOJV-OAHLLOKOSA-N".
- Ruxolitinib synonyms "INCB018424, INC424".
- Ruxolitinib tradename "Jakafi, Jakavi".
- Ruxolitinib unii "82".
- Ruxolitinib verifiedfields "changed".
- Ruxolitinib verifiedrevid "461425696".
- Ruxolitinib watchedfields "changed".
- Ruxolitinib width "150".
- Ruxolitinib subject Category:Nitriles.
- Ruxolitinib subject Category:Non-receptor_tyrosine_kinase_inhibitors.
- Ruxolitinib subject Category:Pyrazoles.
- Ruxolitinib subject Category:Pyrrolopyrimidines.
- Ruxolitinib type Agent114778436.
- Ruxolitinib type CausalAgent100007347.
- Ruxolitinib type Drug103247620.
- Ruxolitinib type Matter100020827.
- Ruxolitinib type Medicine103740161.
- Ruxolitinib type Non-receptorTyrosineKinaseInhibitors.
- Ruxolitinib type PhysicalEntity100001930.
- Ruxolitinib type Substance100020090.
- Ruxolitinib type TyrosineKinaseInhibitor104506005.
- Ruxolitinib type Drug.
- Ruxolitinib type Thing.
- Ruxolitinib type Q8386.
- Ruxolitinib comment "Ruxolitinib (INC424, INCB18424, trade names Jakafi and Jakavi, by Incyte Pharmaceuticals and Novartis) is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of bone marrow cancer. It is also being investigated for the treatment of other types of cancer (such as lymphomas and pancreatic cancer), for polycythemia vera, for plaque psoriasis, and for alopecia areata.".
- Ruxolitinib label "Ruxolitinib".
- Ruxolitinib label "Ruxolitinib".
- Ruxolitinib label "Ruxolitinib".
- Ruxolitinib label "Ruxolitinib".
- Ruxolitinib label "ルキソリチニブ".
- Ruxolitinib sameAs Ruxolitinib.
- Ruxolitinib sameAs Ruxolitinib.
- Ruxolitinib sameAs Ruxolitinib.
- Ruxolitinib sameAs ルキソリチニブ.
- Ruxolitinib sameAs m.0hqvfcr.
- Ruxolitinib sameAs Q7383611.
- Ruxolitinib sameAs Q7383611.
- Ruxolitinib sameAs Ruxolitinib.
- Ruxolitinib wasDerivedFrom Ruxolitinib?oldid=629916075.
- Ruxolitinib depiction Ruxolitinib2DACS.svg.
- Ruxolitinib isPrimaryTopicOf Ruxolitinib.
